Product
AOC 1044
2 clinical trials
4 indications
Indication
Duchenne Muscular DystrophyIndication
Duchenne muscular dystrophyIndication
DuchenneIndication
Exon 44Clinical trial
A Phase 2 Open-label Study to Evaluate the Pharmacodynamics and Long-Term Safety and Tolerability of AOC 1044 Administered Intravenously to DMD Participants With Mutations Amenable to Exon 44 SkippingStatus: , Estimated PCD: 2025-12-31
Clinical trial
A Phase 1/2, Randomized, Placebo-controlled, Double-blind, Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of Single and Multiple Ascending Doses of AOC 1044 Administered Intravenously to Healthy Adult Volunteers and Participants With DMD Mutations Amenable to Exon 44 SkippingStatus: Recruiting, Estimated PCD: 2025-03-01